MACDONALD; Simon John Fawcett

Patent Applications and Registrations

Patent applications and USPTO patent grants for MACDONALD; Simon John Fawcett.The latest application filed is for "citrate salt of the compound (s)-4-((s)-3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthydrin-2-yl)ethyl)p- yrrolidin-1-yl)-3-(3-(2-methoxyethoxy)phenyl) butanoic acid".

Company Profile

3.12.14

MACDONALD; Simon John Fawcett - Stevenage GB
MacDonald; Simon John Fawcett - Hertfordshire GB
Macdonald; Simon John Fawcett - Benington GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Citrate Salt Of The Compound (s)-4-((s)-3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthydrin-2-yl)ethyl)p- Yrrolidin-1-yl)-3-(3-(2-methoxyethoxy)phenyl) Butanoic Acid App 20200291017 - BARRETT; Tim ; et al.	2020-09-17
Naphthyridine derivatives as alpha V beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases Grant 10,513,517 - Anderson , et al. Dec	2019-12-24
Naphthyridine Derivatives As Alpha V Beta 6 Integrin Antagonists For The Treatment Of E.g. Fibrotic Diseases App 20190048005 - ANDERSON; Niall Andrew ; et al.	2019-02-14
Naphthyridine derivatives as alpha v beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases Grant 10,144,733 - Anderson , et al. De	2018-12-04
Compounds alpha v beta 6 integrin antagonists Grant 10,004,724 - Anderson , et al. June 26, 2	2018-06-26
Naphthyridine Derivatives As Alpha V Beta 6 Integrin Antagonists For The Treatment Of E.g. Fibrotic Diseases App 20170291899 - ANDERSON; Niall Andrew ; et al.	2017-10-12
NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS App 20170290818 - ANDERSON; Niall Andrew ; et al.	2017-10-12
Non-Steroidal Glucocorticoid Inhibitors and Their Use in Treating Inflammation, Allergy and Auto-Immune Conditions App 20120277279 - BARNETT; Heather Anne ; et al.	2012-11-01
Non-steroidal glucocorticoid inhibitors and their use in treating inflammation, allergy and auto-immune conditions Grant 8,247,377 - Barnett , et al. August 21, 2	2012-08-21
Indazoles as glucocorticoid receptor ligands Grant 8,093,281 - Eldred , et al. January 10, 2	2012-01-10
Compounds Grant 7,947,727 - Biggadike , et al. May 24, 2	2011-05-24
Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators Grant 7,902,224 - Edwards , et al. March 8, 2	2011-03-08
Novel Compounds App 20100234441 - Barnett; Heather Anne ; et al.	2010-09-16
Novel Compounds App 20100120883 - Biggadike; Keith ; et al.	2010-05-13
Pyrazole Derivatives As Non-steroidal Glucocorticoid Receptor Ligands App 20100035926 - Campbell; Ian Baxter ; et al.	2010-02-11
Indazoles As Glucocorticoid Receptor Ligands App 20090074675 - Eldred; Colin David ; et al.	2009-03-19
Pyrazolo-Pyrimidine Derivatives as Anti-Inflammatory Agents App 20080292561 - Biggadike; Keith ; et al.	2008-11-27
Phenyl-Pyrazole Derivatives as Non-Steroidal Glucocorticoid Receptor Ligands App 20080207725 - Barker; Michael David ; et al.	2008-08-28
Indole derivatives Grant 7,288,564 - Demaine , et al. October 30, 2	2007-10-30
Tetrahydro-Naphthalene Derivatives as Glucocorticoid Receptor Modulators App 20070224130 - Edwards; Christine ; et al.	2007-09-27
Intermediates for preparing neuraminidase inhibitor conjugates Grant 7,230,114 - Judkins , et al. June 12, 2	2007-06-12
Multivalent neuraminidase inhibitor conjugates Grant 7,205,333 - Wu , et al. April 17, 2	2007-04-17
Intermediates for preparing neuraminidase inhibitor conjugates App 20050032853 - Judkins, Brian David ; et al.	2005-02-10
Multivalent neuraminidase inhibitor conjugates App 20040058853 - Wu, Wen-Yang ; et al.	2004-03-25
Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase Grant 6,228,853 - Dowle , et al. May 8, 2	2001-05-08
Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase Grant 5,994,344 - Dowle , et al. November 30, 1	1999-11-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.